{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:50:04Z","timestamp":1777560604713,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2020-120267RB"],"award-info":[{"award-number":["PID2020-120267RB"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2023-152474OB-I00"],"award-info":[{"award-number":["PID2023-152474OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.expneurol.2025.115226","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T04:22:57Z","timestamp":1742444577000},"page":"115226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lack of effects of Resolvin D1 after spinal cord injury in mice"],"prefix":"10.1016","volume":"388","author":[{"given":"Isaac","family":"Francos-Quijorna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Caro-Canton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"S\u00e1nchez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Hern\u00e1ndez-Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e8n","family":"L\u00f3pez-Vales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115226_bb0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20070075","article-title":"Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis","volume":"204","author":"Arnold","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2025.115226_bb0010","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/bph.12665","article-title":"Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR review 7","volume":"171","author":"B\u00e4ck","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2025.115226_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/neu.2006.23.635","article-title":"Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains","volume":"23","author":"Basso","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2025.115226_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B. Methodol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0030","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1007\/s12035-018-0889-z","article-title":"Resolvin D1 halts remote Neuroinflammation and improves functional recovery after focal brain damage via ALX\/FPR2 receptor-regulated MicroRNAs","volume":"55","author":"Bisicchia","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2025.115226_bb0040","doi-asserted-by":"crossref","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchi\u00f9","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2025.115226_bb0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1096\/fj.201801017R","article-title":"Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes","volume":"33","author":"Chiurchi\u00f9","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2025.115226_bb0050","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1073\/pnas.1523212113","article-title":"Beneficial effects of IL-37 after spinal cord injury in mice","volume":"113","author":"Coll-Mir\u00f3","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1152\/physiolgenomics.00081.2005","article-title":"Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity","volume":"22","author":"De Biase","year":"2005","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.expneurol.2025.115226_bb0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3233\/JAD-159008","article-title":"Specialized pro-resolving mediators from Omega-3 fatty acids improve amyloid-\u03b2 phagocytosis and regulate inflammation in patients with minor cognitive impairment","volume":"49","author":"Fiala","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2025.115226_bb0065","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1523\/JNEUROSCI.1395-17.2017","article-title":"Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury","volume":"37","author":"Francos-Quijorna","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0070","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2025.115226_bb0075","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115226_bb0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/STROKEAHA.115.011223","article-title":"Lipoxin A4 reduces inflammation through formyl peptide receptor 2\/p38 MAPK signaling pathway in subarachnoid hemorrhage rats","volume":"47","author":"Guo","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2025.115226_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054342","article-title":"Cell-type-specific gene regulatory networks of pro-inflammatory and pro-resolving lipid mediator biosynthesis in the immune system","volume":"24","author":"Hoch","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0090","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115226_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.expneurol.2025.115226_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0168-9525(97)01223-7","article-title":"A database for post-genome analysis","volume":"13","author":"Kanehisa","year":"1997","journal-title":"Trends Genet."},{"key":"10.1016\/j.expneurol.2025.115226_bb0105","doi-asserted-by":"crossref","first-page":"14478","DOI":"10.1523\/JNEUROSCI.0923-12.2012","article-title":"Beneficial effects of alphaB-crystallin in spinal cord contusion injury","volume":"32","author":"Klopstein","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0110","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.expneurol.2025.115226_bb0120","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1096\/fj.10-159913","article-title":"FPR2\/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis","volume":"24","author":"Maderna","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2025.115226_bb0125","doi-asserted-by":"crossref","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","article-title":"WikiPathways: connecting communities","volume":"49","author":"Martens","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2025.115226_bb0130","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2025.115226_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-121735","article-title":"1\u03b1,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-\u03b2 phagocytosis and inflammation in Alzheimer's disease patients","volume":"34","author":"Mizwicki","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2025.115226_bb0140","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2025.115226_bb0145","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits Polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0150","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85922","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"1","author":"Norling","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2025.115226_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.55782\/ane-2011-1848","article-title":"Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade","volume":"71","author":"Oyinbo","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.expneurol.2025.115226_bb0165","doi-asserted-by":"crossref","first-page":"30697","DOI":"10.1074\/jbc.M115.679068","article-title":"Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis","volume":"290","author":"Poisson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115226_bb0170","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1096\/fj.201600144RR","article-title":"D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization","volume":"30","author":"Pope","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2025.115226_bb0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1750-3639.2011.00488.x","article-title":"Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau","volume":"21","author":"Pr\u00fcss","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1096\/fj.10-169599","article-title":"MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits","volume":"25","author":"Recchiuti","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2025.115226_bb0185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4049\/jimmunol.1101665","article-title":"Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses","volume":"189","author":"Rogerio","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0190","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a selective NLRP3 Inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis","volume":"10","author":"Sanchez-Fernandez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-022-02386-1","article-title":"Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis","volume":"19","author":"Sanchez-Fernandez","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115226_bb0200","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115226_bb0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115226_bb0210","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and Protectins in inflammation-resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.expneurol.2025.115226_bb0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and Maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2025.115226_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical Bayes methods for assessing differential expression in microarray experiments","author":"Smyth Gordon","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0230","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2025.115226_bb0240","series-title":"ggplot2 Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.expneurol.2025.115226_bb0245","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.expneurol.2025.115226_bb0250","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.expneurol.2025.115226_bb0255","article-title":"Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112740","article-title":"The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation","volume":"140","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.expneurol.2025.115226_bb0265","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase A\u03b242 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:58:14Z","timestamp":1762149494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"alternative-id":["S0014488625000901"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115226","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of effects of Resolvin D1 after spinal cord injury in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115226"}}